Zhou, Meng-Qiao <br/><br/>
Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.  [electronic resource] 

 -  Molecular medicine reports  Dec 2017 
 - 8983-8988 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2017.7742  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiotonic Agents--pharmacology<br/>Cell Line<br/>Cell Survival--drug effects<br/>Flavonols--pharmacology<br/>Gene Expression Regulation--drug effects<br/>Inflammation--genetics<br/>Inflammation Mediators--metabolism<br/>Lipopolysaccharides<br/>Myocytes, Cardiac--drug effects<br/>NF-kappa B--metabolism<br/>RNA, Messenger--genetics<br/>Rats<br/>Signal Transduction--drug effects<br/>Toll-Like Receptor 4--metabolism